[go: up one dir, main page]

MX2022003962A - Sistema de control de glucosa en sangre. - Google Patents

Sistema de control de glucosa en sangre.

Info

Publication number
MX2022003962A
MX2022003962A MX2022003962A MX2022003962A MX2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A
Authority
MX
Mexico
Prior art keywords
therapy
value
control parameter
blood glucose
control
Prior art date
Application number
MX2022003962A
Other languages
English (en)
Inventor
Edward R Damiano
Firas H El-Khatib
Michael J Rosinko
David Chi- Wai Lim
Edward B Raskin
Original Assignee
Beta Bionics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2020/042198 external-priority patent/WO2021011699A1/en
Priority claimed from PCT/US2020/042195 external-priority patent/WO2021011697A1/en
Priority claimed from PCT/US2020/042269 external-priority patent/WO2021011738A1/en
Application filed by Beta Bionics Inc filed Critical Beta Bionics Inc
Publication of MX2022003962A publication Critical patent/MX2022003962A/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F8/00—Arrangements for software engineering
    • G06F8/60—Software deployment
    • G06F8/65—Updates
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F8/00—Arrangements for software engineering
    • G06F8/60—Software deployment
    • G06F8/65—Updates
    • G06F8/656—Updates while running
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M2005/1401—Functional features
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3303—Using a biosensor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/609—Biometric patient identification means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A61M5/1408—Infusion of two or more substances in parallel, e.g. manifolds, sequencing valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Software Systems (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Security & Cryptography (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • External Artificial Organs (AREA)

Abstract

La presente invención refiere a un sistema de control de glucosa en sangre, configurado para modificar la terapia administrada a un sujeto y determinar si la terapia modificada da lugar a una mejora estadísticamente significativa del control glucémico. El sistema obtiene información relacionada al control glucémico resultante de la administración de la primera terapia utilizando un primer valor de un parámetro de control y determina un primer efecto correspondiente a la primera terapia. El parámetro de control se ajusta a un segundo valor que difiere del primer valor. El sistema obtiene información de control glucémico resultante de la administración de la segunda terapia utilizando el segundo valor del parámetro de control y determina un segundo efecto correspondiente a la segunda terapia. El sistema puede realizar una evaluación comparativa y determinar si el segundo valor del parámetro de control da lugar a una mejora estadísticamente significativa del control glucémico del sujeto.
MX2022003962A 2019-10-04 2020-10-02 Sistema de control de glucosa en sangre. MX2022003962A (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962911017P 2019-10-04 2019-10-04
US201962910970P 2019-10-04 2019-10-04
US201962911143P 2019-10-04 2019-10-04
US202062987842P 2020-03-10 2020-03-10
US202063037472P 2020-06-10 2020-06-10
PCT/US2020/042198 WO2021011699A1 (en) 2019-07-16 2020-07-15 Ambulatory device and components thereof
PCT/US2020/042195 WO2021011697A1 (en) 2019-07-16 2020-07-15 Blood glucose control system
PCT/US2020/042269 WO2021011738A1 (en) 2019-07-16 2020-07-16 Blood glucose control system
PCT/US2020/054130 WO2021067856A1 (en) 2019-10-04 2020-10-02 Blood glucose control system

Publications (1)

Publication Number Publication Date
MX2022003962A true MX2022003962A (es) 2022-07-21

Family

ID=75336591

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2022003961A MX2022003961A (es) 2019-10-04 2020-10-02 Sistema de control de glucosa en sangre.
MX2022003962A MX2022003962A (es) 2019-10-04 2020-10-02 Sistema de control de glucosa en sangre.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2022003961A MX2022003961A (es) 2019-10-04 2020-10-02 Sistema de control de glucosa en sangre.

Country Status (9)

Country Link
EP (2) EP4042441A4 (es)
JP (2) JP7607291B2 (es)
CN (2) CN114868200A (es)
AU (2) AU2020356952A1 (es)
CA (2) CA3151777A1 (es)
DE (2) DE112020004762T5 (es)
IL (2) IL291671A (es)
MX (2) MX2022003961A (es)
WO (2) WO2021067856A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210060244A1 (en) * 2019-08-28 2021-03-04 Medtronic Minimed, Inc. Method and system for verifying whether a non-medical client device is operating correctly with a medical device controlled by the non-medical client device and causing a notification to be generated
WO2022140204A1 (en) 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
US12394521B2 (en) * 2020-11-11 2025-08-19 Itamar Medical Ltd. Sleep apnea test device
CN116897397A (zh) * 2021-01-29 2023-10-17 拜耳医药保健有限责任公司 用于协议转换的系统、方法和计算机程序产品
WO2022204705A1 (en) * 2021-03-25 2022-09-29 Beta Bionics, Inc. Emergency medicament dose control
FR3133478B1 (fr) * 2022-03-11 2024-11-29 Diabeloop Système informatisé de communication d’informations de traitement à un utilisateur
US12293837B2 (en) * 2022-03-14 2025-05-06 O/D Vision Inc. Systems and methods for artificial intelligence based warning of potential health concerns
CN116328088A (zh) * 2023-03-15 2023-06-27 深圳麦科田生物医疗技术股份有限公司 输注控制参数更新方法、装置、输注泵及存储介质
US20240339190A1 (en) * 2023-04-07 2024-10-10 Abbott Diabetes Care Inc. Management process for insulin therapy using reinforcement learning and therapy escalation pathways
WO2024259265A2 (en) * 2023-06-14 2024-12-19 Arizona Board Of Regents On Behalf Of Arizona State University Systems and methods for modeling and simulating glycemic response for behavioral lifestyle interventions
WO2025023962A1 (en) * 2023-07-24 2025-01-30 Carefusion 303, Inc. Secure control of a medical device
CN117789900B (zh) * 2023-12-08 2024-11-15 北京华益精点生物技术有限公司 血糖数据管理方法及相关设备

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7591801B2 (en) * 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7806854B2 (en) 2005-05-13 2010-10-05 Trustees Of Boston University Fully automated control system for type 1 diabetes
WO2009002620A1 (en) * 2007-06-27 2008-12-31 F. Hoffman-La Roche Ag System and method for developing patient specific therapies based on modeling of patient physiology
US10231077B2 (en) * 2007-07-03 2019-03-12 Eingot Llc Records access and management
AU2010210156B2 (en) * 2009-02-04 2015-01-29 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing glycemic control based on glycemic response information
DK3173014T3 (da) * 2009-07-23 2021-09-13 Abbott Diabetes Care Inc Realtidsstyring af data vedrørende fysiologisk kontrol af glucoseniveauer
WO2011149857A1 (en) * 2010-05-24 2011-12-01 Abbott Diabetes Care Inc. Method and system for updating a medical device
JP6047097B2 (ja) 2010-10-31 2016-12-21 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
US8745298B2 (en) * 2011-10-24 2014-06-03 Roche Diagnostics Operations, Inc. Interoperability enhancement that supports connectivity of applications on a medical device
NZ747032A (en) * 2012-12-21 2020-06-26 Deka Products Lp System and apparatus for electronic patient care
US9242043B2 (en) * 2013-03-15 2016-01-26 Tandem Diabetes Care, Inc. Field update of an ambulatory infusion pump system
EP2851823A1 (en) * 2013-09-20 2015-03-25 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
US10105488B2 (en) * 2013-12-12 2018-10-23 Medtronic Minimed, Inc. Predictive infusion device operations and related methods and systems
US9486580B2 (en) * 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
MX373076B (es) 2014-01-31 2020-07-06 Univ Boston Control de nivel de glucosa fuera de línea basado en periodos anteriores de control de nivel de glucosa en línea.
GB201407896D0 (en) * 2014-05-05 2014-06-18 Joanneum Res Forschungsgmbh Insulin dosage proposal system
EP4241811B1 (en) * 2014-05-27 2025-01-29 ResMed, Inc. Remote respiratory therapy device management
US9669160B2 (en) * 2014-07-30 2017-06-06 Tandem Diabetes Care, Inc. Temporary suspension for closed-loop medicament therapy
EP3261523B1 (en) * 2015-02-27 2023-05-03 Zoll Medical Corporation Downloading and booting method and system for a wearable medical device
CA2978392A1 (en) * 2015-03-24 2016-09-29 Colin LAKE Patient care system
EP3319511B1 (en) 2015-08-07 2021-10-06 Trustees of Boston University Glucose control system with automatic adaptation of glucose target
WO2017031440A1 (en) * 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
CA3009409A1 (en) * 2016-01-05 2017-07-13 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
CN108495665B (zh) * 2016-01-14 2021-04-09 比格福特生物医药公司 调整胰岛素输送速率
US20170259072A1 (en) * 2016-03-14 2017-09-14 Qualcomm Incorporated System architecture for medical implant
US10426342B2 (en) * 2016-03-31 2019-10-01 Zoll Medical Corporation Remote access for ambulatory medical device
JP7019127B2 (ja) 2016-07-15 2022-02-15 ウニヴェルズィテート ベルン 強化学習に基づくインスリンの評価
US11295847B2 (en) 2016-08-26 2022-04-05 Novo Nordisk A/S Systems and methods for adjusting basal administration timing
US10896245B2 (en) * 2016-08-29 2021-01-19 Bigfoot Biomedical, Inc. Network topology for insulin pump systems
AU2018362257B2 (en) * 2017-10-30 2023-01-12 Dexcom, Inc. Diabetes management partner interface for wireless communication of analyte data
EP3729446A1 (en) * 2017-12-21 2020-10-28 Eli Lilly and Company Closed loop control of physiological glucose
EP3603401B1 (en) 2018-08-02 2021-12-08 Radie B.V. Device and method for portioning a dough mass
JP7682453B2 (ja) * 2019-07-16 2025-05-26 ベータ バイオニクス，インコーポレイテッド 血糖制御システム

Also Published As

Publication number Publication date
EP4042441A1 (en) 2022-08-17
CN114902344A (zh) 2022-08-12
IL291671A (en) 2022-05-01
IL291746A (en) 2022-05-01
WO2021067856A1 (en) 2021-04-08
CA3151782A1 (en) 2021-04-08
DE112020004780T5 (de) 2022-09-01
EP4042441A4 (en) 2023-10-11
JP2022551265A (ja) 2022-12-08
JP2023503792A (ja) 2023-02-01
JP7607291B2 (ja) 2024-12-27
AU2020358856A1 (en) 2022-04-14
CN114868200A (zh) 2022-08-05
CA3151777A1 (en) 2021-04-08
WO2021067767A1 (en) 2021-04-08
MX2022003961A (es) 2022-07-21
AU2020356952A1 (en) 2022-04-14
EP4042436A1 (en) 2022-08-17
JP7730109B2 (ja) 2025-08-27
EP4042436A4 (en) 2023-10-04
DE112020004762T5 (de) 2022-08-11

Similar Documents

Publication Publication Date Title
MX2022003962A (es) Sistema de control de glucosa en sangre.
BR112018003845A2 (pt) auxiliares cirúrgicos com medicamentos afetados por materiais ativadores
BR112022026184A2 (pt) Sistema de detecção de enjoo por movimento para veículos autônomos
MX2019011117A (es) Anticuerpo b7-h3, fragmento de union a antigeno de los mismos y uso medico de los mismos.
BR112012019624A2 (pt) sistema e método para administrar medicamentos a um paciente
BR112018003817A2 (pt) materiais auxiliares cirúrgicos com medicamentos afetados por ativadores
BR112014017932A2 (pt) dispositivos de fixação de cateteres
BR112015020804A2 (pt) dispositivo fototerapeutico, método e uso
WO2017062456A3 (en) Biomarkers related to interleukin-33 (il-33)-mediated diseases and uses thereof
BR112017012045A2 (pt) método para interromper instruções de saída de rcp, e, desfibrilador externo automático
CL2018000739A1 (es) Terapia adjuntiva con 25-hidroxi vitamina d y artículos de la misma.
BR112016028643A2 (pt) ?dispositivo de vedação e sistema de entrega?
BR112018003870A2 (pt) construções cirúrgicas tubulares incluindo material auxiliar
CO2021013251A2 (es) Derivados de insulina sensibles a la glucosa
BR112016028446A2 (pt) inibidor de complemento de ornithodoros moubata para uso no tratamento de doenças mediadas por complemento em pacientes com polimorfismo de c5
CO2020000240A2 (es) Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico
BR112018070463A8 (pt) Método e aparelho para prover um regime farmacocinético de dosagem de fármaco
CL2021001389A1 (es) Formulaciones en cápsula
BR112015022650A8 (pt) inibidores de quinase induzível por sal macrocíclico.
WO2018089875A3 (en) Person-centered health record architecture
EP4289430A3 (en) Thrombolytic agent and bevacizumab for treatment of cerebral ischemia
BR112021017878A2 (pt) Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação
BR112018003843A2 (pt) compostos auxiliares cirúrgicos tendo medicamentos liberados de maneira controlável dos mesmos
BR112019002355A2 (pt) composições e métodos para prevenção de acidente vascular cerebral em pacientes pediátricos com anemia falciforme
BR112018010066A2 (pt) agente estimulante do receptor 5-hidroxitriptamina 1b para intensificar potencial de enxerto in vivo